Product logins

Find logins to all Clarivate products below.


Urological Devices | United States | 2017 | Market Analysis

The market for US urological devices will grow at a modest rate through 2025. Urology procedures are impacted by favorable demographic trends, an increasing prevalence of obesity, and a demand for premium-priced technologies that provide improved patient outcomes and lower complication rates. Moreover, the ongoing shift toward value-based care in the US has increased demand for minimally invasive treatments which reduce postoperative pain, and shorten recovery and hospitalization times. 

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for urological devices in the US across a 10-year period.

Related Medtech Insights Reports

Report
ENT Devices – Market Insights – United States
The US ENT device market will grow modestly over the forecast period because a shift toward officebased procedures is driving market expansion. Procedure volume growth will also be driven by the…
Report
Large-Joint Reconstructive Implants – Market Insights – United States
The large-joint reconstructive implant market is driven by an expanding older population and a more active younger population in the US. The shift of procedures to the ASC and outpatient settings…
Report
Urological Devices – Market Insights – Latin America
The Latin American urological device market will continue to expand through 2034, driven by the rising prevalence of kidney stones and UI, aging populations, and growing patient awareness of…
Report
Diagnostic Imaging Equipment Servicing – Market Insights – United States
The US diagnostic imaging equipment servicing market is projected to experience only marginal growth through 2034. Market expansion will be constrained largely by the rising adoption of advanced…
Report
Coronary Artery Bypass Graft Devices – Market Insights – United States
The US CABG device market will be supported by sustained demand for surgical revascularization in patients with increasingly complex CAD, where CABG remains the preferred treatment option…